Company intelligence / Profile preview

ChemDiv Research Institute

San Diego, California, United States

Ownership: Private
Employees: ~596
Development stage: Other

Overview

ChemDiv supports partners' programs through discovery services; over 26 assets in pipeline via partnerships covering oncology, inflammation, CVMD, anti-infectives. Own programs preclinical (e.g., AVN-322 in Phase 2 for Alzheimer's by partner).

Modalities: Small molecule
Industry: Drug Discovery Services

Partnerships

Orionis BiosciencesViriom Inc.University of Texas Medical Branch (UTMB)

Beyond the preview

Go deeper on ChemDiv Research Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChemDiv Research Institute.

Explore the full profile